| CZH16038 is an early-maturing, white grain hybrid that has good yield potential even under MSV stress, along with good resistance to GLS, TLB and rust. |
|
General Information |
| |
Adaptation/Agroecological zone |
600-1500 masl |
| |
Region |
Southern Africa |
| |
Type of product |
Three-way Cross |
| |
|
|
Year first announced |
2017 |
| Grain Yield |
|
|
|
| Grain yield (MEA) (OPT) |
8.6 t/ha |
|
Grain Characteristics |
| Grain yield (MEB) (OPT) |
8.0 t/ha |
|
Grain color |
White |
| Grain yield (MEC) (OPT) |
5.2 t/ha |
|
Grain texture |
Semi-dent |
| Grain yield (MED) (OPT) |
2.4 t/ha |
|
|
|
| Grain yield (MEA) (HD) |
9.1 t/ha |
|
Biotic Stress Performance |
| Grain yield under low N stress |
3.2 t/ha |
|
Turcicum leaf blight (TLB) (1-9) |
3.0 |
| Grain yield under MSV conditions |
7.1 t/ha |
|
Rust (1-9) |
3.0 |
| |
|
|
Maize streak virus (MSV) (1-9) |
1.0 |
| Agronomic Characteristics |
|
Grey leaf spot (GLS) (1-9) |
2.6 |
| Maturity |
124 DAP |
|
Ear rot |
10.3% |
| Anthesis-silking interval |
1.1 Days |
|
Diseases were originally scored on a 1-5 scale but have been converted here to a 1-9 scale, where 1 = Highly resistant; 5 = Tolerant; 9 = Highly susceptible. |
| Bad husk cover |
10.9% |
|
| Ear aspect |
3.0 |
|
|
|
| Plant aspect |
2.8 |
|
Seed Production Characteristics |
| Ear height |
104 cm |
|
Female seed yield |
6.71 t/ha |
| Plant height |
222 cm |
|
|
|
| Stalk lodging |
17.0% |
|
Comments |
| Plant and ear aspects are scored on 1-5 scale, where 1 = desirable and 5 = undesirable characteristics |
|
Product information is based on data from the CIMMYT Southern Africa Maize Regional On-Station 2017 Trials.
Abbreviations:
DAP = Days After Planting
DLL = Dry Lowlands
DMA = Dry Mid-Altitudes
GLS = Grey Leaf Spot
Low N = Managed Low Nitrogen
masl = meters above sea level
MEA = Mega-environment A
MEB = Mega-environment B
MEC = Mega-environment C
MED = Mega-environment D
MSV = Maize Streak Virus
NUE = Nitrogen Use Efficient
TLB = Turcicum Leaf Blight |
| |
| |
|
|
| Further Links |
|
| Full Announcement |
|
| Regional Trial Data Summary |
|
| Regional Trial Site Information |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
